Leading Executives in Chemicals and Pharmaceuticals
David A. Ricks
Chair and Chief Executive Officer, Eli Lilly and Company
Chair and CEO since 2017; long-time Lilly leader credited with strengthening R&D productivity and global growth positioning.
Albert Bourla
Chairman and Chief Executive Officer, Pfizer
Chairman and CEO who led Pfizer through the rapid development and global rollout of its COVID-19 vaccine and is now steering a pipeline-and-cost reset.
Joaquin Duato
Chairman and Chief Executive Officer, Johnson & Johnson
Veteran J&J operator who became CEO in January 2022 and Chairman in January 2023, sharpening the focus on Innovative Medicine and MedTech.
Robert M. Davis
Chairman and Chief Executive Officer, Merck & Co., Inc. (MSD)
Became CEO on July 1, 2021 and Chairman on Dec 1, 2022 after serving as president and CFO; now leading Merck’s next phase of growth.
Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Novartis
CEO since 2018 who transformed Novartis into a focused medicines company and advanced platforms like radioligand and gene/cell therapies.
Company bio | Executive Committee
Paul Hudson
Chief Executive Officer, Sanofi
CEO since 2019 credited with modernizing Sanofi’s strategy and culture while prioritizing breakthrough medicines and vaccines.
Dame Emma Walmsley
Chief Executive Officer, GSK
First woman to lead a major global pharma; CEO since 2017, guiding GSK’s post-spin focus on vaccines and specialty medicines.
Pascal Soriot
Chief Executive Officer, AstraZeneca
CEO since 2012 who led AstraZeneca’s resurgence and high-science pipeline expansion across oncology and other key areas.
Dr. Thomas Schinecker
Chief Executive Officer, Roche Group
Former diagnostics head who became Group CEO in 2023, steering one of the world’s largest biopharma innovators.
Christopher (Chris) Boerner, Ph.D.
Board Chair and Chief Executive Officer, Bristol Myers Squibb
Elevated to CEO in Nov 2023 and Board Chair in Apr 2024 after leading commercialization and operations across BMS’s portfolio.
Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences
Chairman and CEO since 2019; long-time Roche executive now advancing Gilead’s virology, oncology and inflammation franchises.
Robert A. Bradway
Chairman and Chief Executive Officer, Amgen
CEO since 2012 and Chairman since 2013; led Amgen through significant portfolio expansion and global scale-up.
Jim Fitterling
Chair and Chief Executive Officer, Dow
Chair and CEO who led Dow’s transformation toward higher-growth, sustainability-focused materials science businesses.
Lori D. Koch
Chief Executive Officer, DuPont
Named CEO effective June 1, 2024 after serving as CFO; driving DuPont’s next phase of portfolio-focused growth.
Dr. Markus Kamieth
Chairman of the Board of Executive Directors (CEO), BASF
Veteran BASF executive who became CEO and Chairman of the Board of Executive Directors in 2024; leading strategy and Net Zero Accelerator initiatives.
Peter Vanacker
Chief Executive Officer, LyondellBasell
Global chemicals leader and former Neste CEO now steering LyondellBasell’s circularity and sustainability agenda.
Sanjiv Lamba
Chief Executive Officer, Linde plc
Industrial gases veteran appointed CEO on March 1, 2022 after serving as COO and APAC EVP; leading the world’s largest industrial gases company.
François Jackow
Chief Executive Officer, Air Liquide
Career Air Liquide executive who became CEO on June 1, 2022, chairing the Executive Committee and Board membership.
Timothy (Tim) M. Knavish
Chairman and Chief Executive Officer, PPG Industries
Four-decade PPG veteran who became CEO in Jan 2023 and Chairman in Oct 2023; overseeing global coatings and specialty materials growth.
Company bio | Investor release
Heidi G. Petz
President and Chief Executive Officer, The Sherwin-Williams Company
Became President & CEO on Jan 1, 2024, leading the $20B+ global paints and coatings leader’s next phase of execution.
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.